Asha A. Bhatt

Asha A. Bhatt

Auto-generated profile, based on publicly available information

Asha A. Bhatt

Department of Breast Imaging, Moffitt Cancer Center, 10920 McKinley Dr, Tampa, FL 33612, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
PDF file
ABAsha A. Bhatt
Asha A. Bhatt
DWDana H. Whaley
Dana H. Whaley
CLChristine U. Lee
Christine U. Lee
Ultrasound‐guided breast biopsies can be challenging to perform, especially when the target is adjacent to the nipple, skin, or implant or when the target is small and in very posterior, dense fibroglandular tissue. Oftentimes, a slightly modified approach can result in a diagnostic biopsy specimen with minimal complications. After a brief review of basic techniques for ultrasound‐guided breast biopsies that includes a review of conventional breast biopsy devices, a presentation of procedural modifications and techniques to consider for more challenging cases is described. In particular, novel open‐trough and tandem‐needle techniques are detailed. Several cases using these techniques are then presented.

29 June 2019 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
KAKalie Adler
Kalie Adler
NSNaziya Samreen
Naziya Samreen
KGKatrina N. Glazebrook
Katrina N. Glazebrook
ABAsha A. Bhatt
Asha A. Bhatt

9 December 2020 in Journal of Breast Imaging
Verified
Journal Article
Closed access
PDF file
GWGenevieve A Woodard
Genevieve A Woodard
ABAsha A Bhatt
Asha A Bhatt
EKErica M Knavel
Erica M Knavel
KHKatie N Hunt
Katie N Hunt
Clinically, acute mastitis presents as a red, swollen, and painful breast. Targeted ultrasound can be performed to evaluate the extent of infection and for an underlying abscess. Noncomplicated mastitis or a small fluid collection may respond to oral antibiotics without further intervention, but a larger or more complex abscess may require single or serial percutaneous aspiration. Breast infections, particularly those complicated by an abscess, can have a prolonged clinical course, and close follow-up is required. Since the clinical presentation and imaging features of acute infectious mastitis can overlap with other etiologies, such as inflammatory breast cancer and idiopathic granulomatous mastitis, a percutaneous biopsy may be indicated to accurately diagnose patients.

1 December 2023 in RadioGraphics
Verified
Journal Article
Closed access
MCMolly B. Carnahan
Molly B. Carnahan
LHLaura Harper
Laura Harper
PBParker J. Brown
Parker J. Brown
ABAsha A. Bhatt
Asha A. Bhatt
SESarah Eversman
Sarah Eversman
BPBhavika K. Patel
Bhavika K. Patel
Contrast-enhanced mammography (CEM) is a relatively new breast imaging modality that uses intravenous contrast material to increase detection of breast cancer. CEM combines the structural information of conventional mammography with the functional information of tumor neovascularity. Initial studies have demonstrated that CEM and MRI perform with similar accuracies, with CEM having a slightly higher specificity (fewer false positives), although larger studies are needed. There are various reasons for false positives and false negatives at CEM. False positives at CEM can be caused by benign lesions with vascularity, including benign tumors, infection or inflammation, benign lesions in the skin, and imaging artifacts. False negatives at CEM can be attributed to incomplete or inadequate visualization of lesions, marked background parenchymal enhancement (BPE) obscuring cancer, lack of lesion contrast enhancement due to technical issues or less-vascular cancers, artifacts, and errors of lesion perception or characterization. When possible, real-time interpretation of CEM studies is ideal. If additional views are necessary, they may be obtained while contrast material is still in the breast parenchyma. Until recently, a limitation of CEM was the lack of CEM-guided biopsy capability. However, in 2020, the U.S. Food and Drug Administration cleared two devices to support CEM-guided biopsy using a stereotactic biopsy technique. The authors review various causes of false-positive and false-negative contrast-enhanced mammograms and discuss strategies to reduce these diagnostic errors to improve cancer detection while mitigating unnecessary additional imaging and procedures. ©RSNA, 2023 Quiz questions for this article are available in the supplemental material.

1 October 2023 in RadioGraphics
Verified
Journal Article
Closed access
LHLaura K. Harper
Laura K. Harper
MCMolly B. Carnahan
Molly B. Carnahan
ABAsha A. Bhatt
Asha A. Bhatt
CSCurtis L. Simmons
Curtis L. Simmons
BPBhavika K. Patel
Bhavika K. Patel
RSRichard Sharpe
Richard Sharpe
High-risk lesions of the breast are frequently encountered in percutaneous biopsy specimens. While benign, these lesions have historically undergone surgical excision due to their potential to be upgraded to malignancy. However, there is emerging evidence that a tailored management approach should be considered to reduce overtreatment of these lesions. Flat epithelial atypia (FEA) and atypical ductal hyperplasia (ADH) are two of the most commonly encountered high-risk lesions. FEA has been shown to have a relatively low rate of progression to malignancy, and some guidelines are now recommending observation over routine excision in select cases. Selective observation may be reasonable in cases where the target lesion is small and completely removed at biopsy and when there are no underlying risk factors, such as a history of breast cancer or genetic mutation or concurrent ADH. ADH has the highest potential upgrade rate to malignancy of all the high-risk lesions. Most society guidelines continue to recommend surgical excision of this lesion. More recently, some literature suggests that ADH lesions that appear completely removed at biopsy, involve limited foci (less than two or three) with no necrosis or significant atypia, manifest as a small group of mammographic calcifications, or demonstrate no enhancement at MRI may be reasonable for observation. Ultimately, management of all high-risk lesions must be based on a multidisciplinary approach that considers all patient, radiologic, clinical, and histopathologic factors. ©RSNA, 2023 Quiz questions for this article are available in the supplemental material.

1 January 2023 in RadioGraphics
Verified
Journal Article
Closed access
LHLaura K. Harper
Laura K. Harper
CSCurtis L. Simmons
Curtis L. Simmons
GWGenevieve A. Woodard
Genevieve A. Woodard
MSMalvika H. Solanki
Malvika H. Solanki
ABAsha A. Bhatt
Asha A. Bhatt
Breast masses in children and adolescents are rare and predominantly benign, and knowledge of the clinical presentation and imaging features of the various stages of normal development and mass-for... Breast masses in children and adolescents are uncommon, and the spectrum of pediatric breast masses is predominantly benign and different from that in adults. Knowledge of the clinical presentation...